Skip to content

Effects of probiotic (BC30) supplementation on exercise-induced muscle damage, perceived recovery and athletic performance

Effects of co-administration of probiotic (Bacillus coagulans GBI-30, 6086) and protein (Casein) on markers of skeletal muscle damage, perceived recovery and athletic performance after an intense single leg training bout

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN21076380
Enrollment
38
Registered
2015-09-07
Start date
2015-02-23
Completion date
Unknown
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Probiotic supplementation Nutritional, Metabolic, Endocrine Probiotic supplementation

Interventions

Healthy, recreationally trained male athletes consume 20g of casein (Control = CON) for 2 weeks (days 1-14), followed by a muscle-damaging exercise bout on day 15, perceptual measures on day 16 (24 ho
Ganeden Biotech Inc., Maryfield Heights, OH) for two weeks (days 25-38). A muscle-damaging exercise bout is then performed on day 39, perceptual measures on day 40 (24 hours post exercise), perceptua

Sponsors

Ganeden Biotech Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Normal, healthy individuals 2. Aged between 18-25 years 3. Recreationally Trained Males 4. Must be able to perform required testing

Exclusion criteria

Exclusion criteria: 1. Subjects consuming any ergogenic sports nutrition supplements (incl. creatine, HMB, PA, ATP, carnitine or beta-alanine) at least 4 weeks prior to the beginning of the study. 2. Use of prescription medications (antibiotics, NSAIDs) 3. Use of probiotics or digestive enzymes 4. Smokers 5. Presence of any musculoskeletal, medical, or metabolic contraindications.

Design outcomes

Primary

MeasureTime frame
1. Perceptual measures of recovery [muscle soreness and perceived recovery] will be assessed using the visual analogue scale [VAS]. 2. Markers of muscle damage determined: 2.1. Blood Creatine Kinase (CK) 2.2. Blood Urea Nitrogen (BUN) 2.3. Muscle Swelling (MS) will be assessed via two-dimensional, B-mode ultrasonography (GE, LoGIQ e) to determine muscle thickness of the vastus lateralis (VL) 3. Athletic Performance: 3.1. Single-Leg 1RM (1RM): will be assessed via one repetition maximum testing (1RM) in the one-legged leg press. Three maximal attempts will be allotted with the greatest 1 RM counting for final data. 3.2. Single-Leg Vertical Jump Peak Power (VJPP): will be assessed via maximal vertical jump peak power bout using a Tendo Unit (Trencin, Slovak Republic). Three maximal attempts will be allotted with the greatest peak power counting for final data. Participants will 60 seconds between vertical jump attempts. 3.3. Wingate Peak Power (WPP): will be assessed via Monark Wingate cycle ergometry (Monark™, Vansbro, Sweden). During the cycling test, the volunteer will be instructed to cycle against a predetermined resistance (7.5% of body mass) as fast as possible for 10 seconds.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026